Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Maintains Outperform on Salesforce, Raises Price Target to $325

Author: Benzinga Newsdesk | February 12, 2024 08:44am
Oppenheimer analyst Brian Schwartz maintains Salesforce (NYSE:CRM) with a Outperform and raises the price target from $300 to $325.

Posted In: CRM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist